PSYENCE BIOMEDICAL LTD Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
PSYENCE BIOMEDICAL LTD (PBM) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $317.88 thousand for the 12-month period ending 2024-03-31, per its 6-K filed 2025-01-23.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2025-01-23
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 6 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|---|
| 2024-03-31 | $317.88K 6-K · filed 2025-01-23 | |
| 2023-09-30 | $40.70K 6-K · filed 2025-01-23 | |
| 2023-03-31 | $221.29K 6-K · filed 2025-01-23 |